Skip to main content
. Author manuscript; available in PMC: 2014 May 2.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007482. doi: 10.1002/14651858.CD007482.pub2
Methods Randomized, placebo-controlled trial; 3 parallel groups.
Unit of randomization: individual.
Participants Dates of data collection: September 1980 to November 1981.
Setting: Hopital Saint-Luc, Montreal, Canada.
Inclusion criteria: women undergoing non-elective CS.
Exclusion criteria: not in labor with intact membranes, allergy to cephalosporins, antibiotic use within 48 hours, fever, ruptured membranes for > 36 hours
Interventions Cefoxitin 2 g IV (N = 30) vs cefazolin 1 g IV (N = 30) vs placebo (N = 29) at clamping of the cord and at 6 and 12 hours later. Both treatment groups have been combined
Outcomes Endometritis, wound infection, UTI (symptoms or two successive positive cultures) septicemia, pelvic abscess, pelvic thrombophlebitis. Follow up at 6 weeks. No side effects observed
Notes There were no serious infections in any of the groups.
In the placebo and cefazolin groups there was no increase in aerobic bacterial colonization of the cervix after 4 days but there was an increase in colonization by anaerobes; the opposite occurred in the group receiving cefoxitin
Class of antibiotic: first generation cephalosporin vs second generation cephalosporin (cefamycin)
Subgroups:
  • non-elective CS;

  • after cord clamping.

Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Randomized; method not described.
Allocation concealment? Yes “A number (1 to 90) identified the boxes. The number was allocated randomly to a box.”
An envelope containing the randomization code was available in case of adverse reactions
Blinding? Yes Described as “double blind”.
All outcomes Placebo-controlled: “vitamin solution with a similar colour as the other preparations”
Incomplete outcome data addressed? Unclear No loss to follow up.
All outcomes 1 patient in the control group was excluded from analysis as no cultures were performed As treated analysis performed.
Free of selective reporting? Unclear Insufficient information to judge.
Free of other bias? Unclear The groups were comparable regarding demographic characters.
Overall low risk of bias? Unclear Mostly unclear.
HHS Vulnerability Disclosure